7 Pharma Firms Eye Generic Semaglutide, Prices May Fall 50% Post Patent Expiry: Report Parthika Patel27 Feb 2026 7:40 PM ISTNew Delhi: Prices of widely used weight-loss drugs such as Wegovy and Ozempic are expected to drop significantly in India after the semaglutide patent...
Dr Reddy's Prepares Generic Semaglutide Entry Under Brand Obeda, Targets 60% Price Cut: Report Parthika Patel26 Feb 2026 10:01 PM ISTMumbai: Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name...
CagriSema Fails to Demonstrate Noninferiority to Tirzepatide for Weight Loss: Phase 3 REDEFINE Trial Dr. Kamal Kant Kohli24 Feb 2026 9:15 AM ISTTopline results from a phase 3 clinical trial compared CagriSema with tirzepatide in patients with obesity. CagriSema is a fixed-dose combination of...
Natco Pharma's Generic Semaglutide to Hit Indian Market in March Parthika Patel14 Feb 2026 9:26 PM ISTNew Delhi: Natco Pharma Limited has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market...
Semaglutide Improves Glycemic Control in Adolescents With Obesity: Study Medha Baranwal13 Feb 2026 11:45 AM ISTUSA: A secondary analysis of the 68-week STEP TEENS trial, published in Diabetes Care, found that semaglutide 2.4 mg significantly improved insulin...
OneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout Parthika Patel12 Feb 2026 11:26 PM ISTNew Delhi: OneSource Specialty Pharma Limited has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic...
Once-Weekly Semaglutide Outperforms Daily Liraglutide for weight loss and HbA1c reduction in Diabetes Patients: Study Dr. Shravani Dali11 Feb 2026 9:00 AM ISTResearchers have found in a new real-world Pakistani cohort, once-weekly semaglutide achieved greater weight loss and HbA1c reduction than daily...
Natco Pharma Gets Court Nod to Make, Export Semaglutide for Diabetes and Obesity Markets Susmita Roy10 Feb 2026 7:32 PM ISTNew Delhi: Natco Pharma has secured regulatory clearance from the High Court to manufacture semaglutide and export the drug to select international...
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales Warning sheeba farhat6 Feb 2026 11:15 AM ISTNew Delhi: Novo Nordisk's shares tumbled on Wednesday, knocking nearly USD 50 billion in value from the Danish obesity drug giant, as it warned that...
Emcure Beats 9 Rivals to Secure Second Semaglutide Brand from Novo Nordisk for India Parthika Patel5 Feb 2026 10:31 PM ISTNew Delhi: Emcure Pharmaceuticals has secured exclusive rights to market a second brand of semaglutide in India through a partnership with Novo...
SURPASS-2- Tirzepatide vs Semaglutide in Type 2 Diabetes Deeksha Bhandari4 Feb 2026 12:30 PM ISTKey Summary: In addition to meeting the primary objective of noninferiority to semaglutide in type 2 diabetes (T2D), tirzepatide, at a dose of...
Cagrilintide-Semaglutide combo Improves Weight Loss and Glycemic Control in T2DM, finds trial Dr. Kamal Kant Kohli3 Feb 2026 8:45 PM ISTTopline results from the REIMAGINE 2 trial involving 2,728 adults with type 2 diabetes inadequately controlled on metformin showed that combined...
